PMV Pharmaceuticals, Inc. - COMMON STOCK (PMVP)
CUSIP: 69353Y103
Q4 2021 13F Holders as of 31 Dec 2021
- Type / Class
- Equity / COMMON STOCK
- Shares outstanding
- 53,185,766
- Total 13F shares
- 47,470,437
- Share change
- +1,136,682
- Total reported value
- $1,096,597,184
- Price per share
- $23.10
- Number of holders
- 102
- Value change
- +$15,190,740
- Number of buys
- 62
- Number of sells
- 31
Quarterly Holders Quick Answers
What is CUSIP 69353Y103?
CUSIP 69353Y103 identifies PMVP - PMV Pharmaceuticals, Inc. - COMMON STOCK in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Related Filing Research
- Latest 13F filings for newly reported positions.
- Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
- Latest 10-Q/10-K reports for financial context tied to this issuer.
- Recent insider transactions for executive and insider activity.
- SEC investors directory and top value investors for manager drilldown.
- Back to full security ownership history.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 69353Y103:
Top shareholders of PMVP - PMV Pharmaceuticals, Inc. - COMMON STOCK (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC |
13F
|
Company |
14%
|
7,330,423
|
$218,447,000 | — | 30 Sep 2021 | |
| INTERWEST VENTURE MANAGEMENT CO |
13F
|
Company |
7.3%
|
3,869,911
|
$115,323,000 | — | 30 Sep 2021 | |
| Avoro Capital Advisors LLC |
13F
|
Company |
5.5%
|
2,925,000
|
$87,165,000 | — | 30 Sep 2021 | |
| Euclidean Capital LLC |
13F
3/4/5
|
Company · 10%+ Owner |
5.2%
|
2,769,813
|
$82,540,000 | — | 30 Sep 2021 | |
| VANGUARD GROUP INC |
13F
|
Company |
5%
|
2,653,394
|
$79,071,000 | — | 30 Sep 2021 | |
| Boxer Capital, LLC |
13F
|
Company |
4.3%
|
2,268,236
|
$67,593,000 | — | 30 Sep 2021 | |
| BlackRock Finance, Inc. |
13F
|
Company |
4.1%
|
2,187,923
|
$65,199,000 | — | 30 Sep 2021 | |
| STATE STREET CORP |
13F
|
Company |
3.4%
|
1,818,342
|
$54,187,000 | — | 30 Sep 2021 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
3.4%
|
1,807,092
|
$53,852,000 | — | 30 Sep 2021 | |
| VIKING GLOBAL INVESTORS LP |
13F
|
Company |
3.4%
|
1,790,284
|
$53,350,000 | — | 30 Sep 2021 | |
| RA CAPITAL MANAGEMENT, L.P. |
13F
|
Company |
3.2%
|
1,710,265
|
$50,966,000 | — | 30 Sep 2021 | |
| ALKEON CAPITAL MANAGEMENT LLC |
13F
|
Company |
2.7%
|
1,419,553
|
$42,303,000 | — | 30 Sep 2021 | |
| Logos Global Management LP |
13F
|
Company |
2.6%
|
1,400,000
|
$41,720,000 | — | 30 Sep 2021 | |
| VICTORY CAPITAL MANAGEMENT INC |
13F
|
Company |
2%
|
1,051,393
|
$31,331,000 | — | 30 Sep 2021 | |
| RTW INVESTMENTS, LP |
13F
|
Company |
1.5%
|
809,863
|
$24,134,000 | — | 30 Sep 2021 | |
| DEERFIELD MANAGEMENT COMPANY, L.P. |
13F
|
Company |
1.5%
|
804,000
|
$23,959,000 | — | 30 Sep 2021 | |
| FMR LLC |
13F
|
Company |
1.2%
|
654,400
|
$19,501,000 | — | 30 Sep 2021 | |
| ArrowMark Colorado Holdings LLC |
13F
|
Company |
0.99%
|
527,420
|
$15,717,000 | — | 30 Sep 2021 | |
| PRINCIPAL FINANCIAL GROUP INC |
13F
|
Company |
0.92%
|
489,935
|
$14,600,000 | — | 30 Sep 2021 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.82%
|
433,473
|
$12,917,000 | — | 30 Sep 2021 | |
| Woodline Partners LP |
13F
|
Company |
0.77%
|
407,365
|
$12,139,000 | — | 30 Sep 2021 | |
| PERSONAL CFO SOLUTIONS, LLC |
13F
|
Company |
0.67%
|
355,342
|
$10,589,000 | — | 30 Sep 2021 | |
| JENNISON ASSOCIATES LLC |
13F
|
Company |
0.67%
|
354,049
|
$10,551,000 | — | 30 Sep 2021 | |
| INTERWEST PARTNERS X LP |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
4,502,480
|
$10,040,531 | — | 13 Jul 2021 | |
| PERCEPTIVE ADVISORS LLC |
13F
|
Company |
0.57%
|
301,714
|
$8,991,000 | — | 30 Sep 2021 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.55%
|
293,840
|
$8,756,000 | — | 30 Sep 2021 | |
| PFM Health Sciences, LP |
13F
|
Company |
0.54%
|
288,334
|
$8,592,000 | — | 30 Sep 2021 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.48%
|
253,076
|
$7,541,000 | — | 30 Sep 2021 | |
| FEDERATED HERMES, INC. |
13F
|
Company |
0.47%
|
250,000
|
$7,450,000 | — | 30 Sep 2021 | |
| SPHERA FUNDS MANAGEMENT LTD. |
13F
|
Company |
0.36%
|
190,525
|
$5,678,000 | — | 30 Sep 2021 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.35%
|
187,163
|
$5,578,000 | — | 30 Sep 2021 | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC |
13F
|
Company |
0.35%
|
186,162
|
$5,547,628 | — | 30 Sep 2021 | |
| Invesco Ltd. |
13F
|
Company |
0.32%
|
172,726
|
$5,147,000 | — | 30 Sep 2021 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
0.29%
|
151,778
|
$4,523,000 | — | 30 Sep 2021 | |
| FRED ALGER MANAGEMENT, LLC |
13F
|
Company |
0.24%
|
125,211
|
$3,731,000 | — | 30 Sep 2021 | |
| Commodore Capital LP |
13F
|
Company |
0.24%
|
125,000
|
$3,725,000 | — | 30 Sep 2021 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.2%
|
107,265
|
$3,197,000 | — | 30 Sep 2021 | |
| Asymmetry Capital Management, L.P. |
13F
|
Company |
0.19%
|
100,882
|
$3,006,000 | — | 30 Sep 2021 | |
| Octagon Capital Advisors LP |
13F
|
Company |
0.19%
|
100,141
|
$2,984,000 | — | 30 Sep 2021 | |
| UBS Group AG |
13F
|
Company |
0.18%
|
96,038
|
$2,862,000 | — | 30 Sep 2021 | |
| Thilo Schroeder |
3/4/5
|
Director |
—
class O/S missing
|
1,101,283
|
$2,455,861 | — | 06 Oct 2021 | |
| Rafferty Asset Management, LLC |
13F
|
Company |
0.15%
|
79,449
|
$2,368,000 | — | 30 Sep 2021 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.15%
|
77,376
|
$2,306,000 | — | 30 Sep 2021 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.11%
|
59,246
|
$1,766,000 | — | 30 Sep 2021 | |
| Assenagon Asset Management S.A. |
13F
|
Company |
0.11%
|
56,960
|
$1,697,000 | — | 30 Sep 2021 | |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC |
13F
|
Company |
0.1%
|
54,417
|
$1,622,000 | — | 30 Sep 2021 | |
| CITIGROUP INC |
13F
|
Company |
0.1%
|
53,885
|
$1,606,000 | — | 30 Sep 2021 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
0.1%
|
53,000
|
$1,579,000 | — | 30 Sep 2021 | |
| PRUDENTIAL FINANCIAL INC |
13F
|
Company |
0.1%
|
51,868
|
$1,545,000 | — | 30 Sep 2021 | |
| EcoR1 Capital, LLC |
13F
|
Company |
0.09%
|
50,000
|
$1,490,000 | — | 30 Sep 2021 |
Institutional Holders of PMV Pharmaceuticals, Inc. - COMMON STOCK (PMVP) as of Q4 2021
As of 31 Dec 2021,
PMV Pharmaceuticals, Inc. - COMMON STOCK (PMVP) was held by
102 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
47,470,437 shares.
The largest 10 holders included
ORBIMED ADVISORS LLC, INTERWEST VENTURE MANAGEMENT CO, JPMORGAN CHASE & CO, RTW INVESTMENTS, LP, BOXER CAPITAL, LLC, VANGUARD GROUP INC, BlackRock Inc., Euclidean Capital LLC, VIKING GLOBAL INVESTORS LP, and RA CAPITAL MANAGEMENT, L.P..
This page lists
102
institutional shareholders reporting positions in this security
for the Q4 2021 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2021 vs Q3 2021 Across Filers
Q3 2021 holders
91
Q4 2021 holders
102
Holder diff
11
| Investor | Q3 2021 Shares | Q4 2021 Shares | Share Diff | Share Chg % | Q3 2021 Value $ | Q4 2021 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.